Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - oxaliplatin, quantity: 50 mg - injection, intravenous infusion - excipient ingredients: water for injections; sodium hydroxide; tartaric acid - oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: - adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour. - treatment of advanced colorectal cancer.

Canada - English - Health Canada

sandoz canada incorporated - oxaliplatin - solution - 5mg - oxaliplatin 5mg - antineoplastic agents

Canada - English - Health Canada

eugia pharma inc. - oxaliplatin - solution - 5mg - oxaliplatin 5mg

Canada - English - Health Canada

fresenius kabi canada ltd - oxaliplatin - solution - 5mg - oxaliplatin 5mg - antineoplastic agents

Canada - English - Health Canada

dr reddy's laboratories ltd - oxaliplatin - solution - 5mg - oxaliplatin 5mg - antineoplastic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - oxaliplatin -

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - oxaliplatin -

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - oxaliplatin -

Ireland - English - HPRA (Health Products Regulatory Authority)

medac gesellschaft für klinische spezialpräparate mbh - oxaliplatin - powder for solution for infusion - 5 milligram(s)/millilitre - platinum compounds; oxaliplatin

United States - English - NLM (National Library of Medicine)

mylan institutional llc - oxaliplatin (unii: 04zr38536j) (oxaliplatin - unii:04zr38536j) - oxaliplatin 50 mg in 10 ml